Docetaxel chemotherapy plus androgen-deprivation therapy in high-volume disease metastatic hormone-sensitive prostate cancer in Chinese patients: an efficacy and safety analysis

Docetaxel chemotherapy plus androgen-deprivation therapy in high-volume disease metastatic hormone-sensitive prostate cancer in Chinese patients: an efficacy and safety analysis

Abstract Objective To investigate the efficacy and safety of docetaxel chemotherapy combined with androgen-deprivation therapy for patients with high-volume disease metastatic hormone-sensitive prostate cancer. Methods 153 cases of high-volume disease metastatic hormone-sensitive prostate cancer in...

Olles dieđut

Bibliográfalaš dieđut
Váldodahkkit: Zhuifeng Guo, Xuwei Lu, Fan Yang, Liang Qin, Ning Yang, Jiawen Wu, Hang Wang
Materiálatiipa: Artihkal
Giella:English
Almmustuhtton: BMC 2022-08-01
Ráidu:European Journal of Medical Research
Fáttát:
Prostate cancer
High-volume disease
Metastatic
Hormone-sensitive
Docetaxel
Androgen-deprivation therapy
Liŋkkat:https://doi.org/10.1186/s40001-022-00773-1

Interneahtta

https://doi.org/10.1186/s40001-022-00773-1

Geahča maid